- Home
- NXL vs ZBAI Comparison
NXL vs ZBAI Comparison
Compare NXL & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- ZBAI
- Stock Information
- Founded
- NXL 2010
- ZBAI 2015
- Country
- NXL United States
- ZBAI United States
- Employees
- NXL N/A
- ZBAI N/A
- Industry
- NXL Medical Specialities
- ZBAI Professional Services
- Sector
- NXL Health Care
- ZBAI Consumer Discretionary
- Exchange
- NXL Nasdaq
- ZBAI Nasdaq
- Market Cap
- NXL 21.0M
- ZBAI 17.3M
- IPO Year
- NXL 2022
- ZBAI N/A
- Fundamental
- Price
- NXL $1.04
- ZBAI $0.33
- Analyst Decision
- NXL Strong Buy
- ZBAI
- Analyst Count
- NXL 1
- ZBAI 0
- Target Price
- NXL $5.00
- ZBAI N/A
- AVG Volume (30 Days)
- NXL 81.9K
- ZBAI 2.4M
- Earning Date
- NXL 08-07-2025
- ZBAI 06-06-2025
- Dividend Yield
- NXL N/A
- ZBAI N/A
- EPS Growth
- NXL N/A
- ZBAI N/A
- EPS
- NXL N/A
- ZBAI N/A
- Revenue
- NXL $131,065.00
- ZBAI $720,000.00
- Revenue This Year
- NXL $79.59
- ZBAI N/A
- Revenue Next Year
- NXL $334.65
- ZBAI N/A
- P/E Ratio
- NXL N/A
- ZBAI N/A
- Revenue Growth
- NXL N/A
- ZBAI 44.00
- 52 Week Low
- NXL $0.59
- ZBAI $0.31
- 52 Week High
- NXL $4.49
- ZBAI $2.50
- Technical
- Relative Strength Index (RSI)
- NXL 29.65
- ZBAI N/A
- Support Level
- NXL $1.12
- ZBAI N/A
- Resistance Level
- NXL $1.30
- ZBAI N/A
- Average True Range (ATR)
- NXL 0.09
- ZBAI 0.00
- MACD
- NXL 0.00
- ZBAI 0.00
- Stochastic Oscillator
- NXL 0.00
- ZBAI 0.00
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.